Joshua S. Prince - Jun 24, 2024 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
Chief Operating Officer
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
Jun 24, 2024
Transactions value $
$0
Form type
4
Date filed
6/26/2024, 09:29 PM
Previous filing
Nov 3, 2023
Next filing
Jul 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTGN Stock Option (Right to Buy) Award $0 +150K $0.00 150K Jun 24, 2024 Common Stock 150K $3.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the "Vesting Start Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date.